Please login to the form below
Clinical trial optimisation
This page shows the latest Clinical trial optimisation news and features for those working in and with pharma, biotech and healthcare.
Syneos Health announces partnership with AiCure
The partnership will see AiCure leverage Syneos’ behavioural insights-driven product development model, with the aim to capture, analyse and predict patient behaviours influencing clinical trial adherence. ... By deploying the AiCure platform to our
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Adopting a holistic approach in crafting a product’s value story: utilising HEOR and RWE throughout the product life cycle
By evaluating alternatives for disease area prioritisation and estimating the impact of the product in the clinical pathway, early HE models will deliver insights on where the product adds the most ... For example, understanding the current epidemiology
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
